200230 — Telcon RF Pharmaceutical Cashflow Statement

0.000.00%

Last trade - 00:00

TechnologySpeculativeSmall CapValue Trap

Annual cashflow statement for Telcon RF Pharmaceutical, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-52,801	-44,187	-23,207	-42,117	13,949
Depreciation
Amortisation
Non-Cash Items	58,948	39,163	21,737	39,623	-12,194
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-5,566	3,204	-3,088	-3,880	-7,133
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities	5,013	2,576	-359	-2,093	-1,135
Capital Expenditures	-1,079	-1,200	-5,813	-834	-1,898
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	961	-60,878	6,692	-7,052	-8,627
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-118	-62,078	879	-7,885	-10,525
Financing Cash Flow Items	1.17	17.7	31	—	485
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	3,804	68,327	-1,891	-3,440	10,445
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	8,489	8,814	-1,346	-13,462	-1,214